Reports
Sale
Global Dry Eye Syndrome Market Growth, Share, Size, Trends: By Disease Type: Evaporative Dry Eye Syndrome, Aqueous Dry Eye Syndrome; By Drug Type: Anti-Inflammatory Drugs, Lubricant Eye Drops, Autologous Serum Eye Drops; By Product; By Distribution Channel; Regional Analysis; Market Dynamic; Competitive Landscape; 2024-2032
Global Dry Eye Syndrome Market Outlook
The global dry eye syndrome market size was worth USD 4.26 billion in 2023. The market is further expected to grow at a CAGR of 6.8% between 2024 and 2032 to reach a value of approximately USD 7.72 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The R&D partnership and the Choice and Lice agreement for the development of gene therapy vectors for retinal diseases were concluded in June 2020 with Santen Pharmaceutical Co., Ltd. and Oxford Biomedica. This R&D partnership primarily aims to produce pre-clinical evidence for OXB's idea for the treatment of inherited retinal diseases using lentiviral vectors. This will support the company's product growth, which will also aid the growth of the overall market.
Market Segmentation
Dry eye syndrome, scientifically identified as keratoconjunctivitis sicca (KCS), refers to a distinguishing concept of the person's eye surface that lacks lubrication or moisture. It is a severe disease that can affect virtually everyone. Several dry eye signs include nausea and burning sensations, eyes swollen, red eyes, fatigued eyes, itchy eyes, and photophobia, among others. In addition, watery eyes may also be a symptom, as a dry eye surface over-stimulates the development of watery tears to alleviate the dryness. Dry eye disease can be caused by excessive use of computers, allergies, obesity, menopause, smoking, LASIK eye surgery, and hormone replacement therapy, among others.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on disease type, the market is divided into the following:
- Evaporative
- Aqueous
Based on drug type, the market can be divided into the following:
- Anti-Inflammatory Drugs
- Lubricant Eye Drops
- Autologous Serum Eye Drops
On the basis of product, the industry can be segmented into:
- Liquid Drops
- Gel
- Liquid Wipes
- Eye Ointment
- Others
Based on distribution channel, the market can be divided into the following:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
The regional markets for the product include North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
The development of the global dry eye syndrome market is largely due to the rise in the widespread occurrence of dry eye syndrome, which is attributed to a variety of factors. The increasing geriatric population around the world has resulted in a rise in the incidence of the syndrome because tear glands weaken because of their ageing and cannot produce enough tear fluid to hold a lubricating film on the eyes. Another key factor for the rising incidence of dry eye syndrome is the higher prevalence of other conditions, which can affect the functioning of the eye like diabetes. The changes in patient's blood composition due to diabetes will adversely affect the weeping glands, causing dry eye syndrome. Many diseases that can cause dry-eye syndrome indirectly include vitamin A deficiency, lupus, thyroid disease, and rheumatoid arthritis. The growing occurrence of such diseases in the market is expected to aid the overall market growth.
Competitive Landscape
The report gives a detailed analysis of the following key players in the global dry eye syndrome market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Akorn, Incorporated.
- AbbVie
- Auven Therapeutics
- Nicox S.A.
- Novartis AG
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Disease Type |
|
| Breakup by Drug Type |
|
| Breakup by Product |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Dry Eye Syndrome Market Analysis
8.1 Key Industry Highlights
8.2 Global Dry Eye Syndrome Historical Market (2018-2023)
8.3 Global Dry Eye Syndrome Market Forecast (2024-2032)
8.4 Global Dry Eye Syndrome Market by Disease Type
8.4.1 Evaporative Dry Eye Syndrome
8.4.1.1 Historical Trend (2018-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.2 Aqueous Dry Eye Syndrome
8.4.2.1 Historical Trend (2018-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.5 Global Dry Eye Syndrome Market by Drug Type
8.5.1 Anti-Inflammatory Drugs
8.5.1.1 Historical Trend (2018-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.2 Lubricant Eye Drops
8.5.2.1 Historical Trend (2018-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.5.3 Autologous Serum Eye Drops
8.5.3.1 Historical Trend (2018-2023)
8.5.3.2 Forecast Trend (2024-2032)
8.6 Global Dry Eye Syndrome Market by Product
8.6.1 Liquid Drops
8.6.1.1 Historical Trend (2018-2023)
8.6.1.2 Forecast Trend (2024-2032)
8.6.2 Gel
8.6.2.1 Historical Trend (2018-2023)
8.6.2.2 Forecast Trend (2024-2032)
8.6.3 Liquid Wipes
8.6.3.1 Historical Trend (2018-2023)
8.6.3.2 Forecast Trend (2024-2032)
8.6.4 Eye Ointment
8.6.4.1 Historical Trend (2018-2023)
8.6.4.2 Forecast Trend (2024-2032)
8.6.5 Others
8.7 Global Dry Eye Syndrome Market by Distribution Channel
8.7.1 Hospital Pharmacies
8.7.1.1 Historical Trend (2018-2023)
8.7.1.2 Forecast Trend (2024-2032)
8.7.2 Retail Pharmacies
8.7.2.1 Historical Trend (2018-2023)
8.7.2.2 Forecast Trend (2024-2032)
8.7.3 Online Pharmacies
8.7.3.1 Historical Trend (2018-2023)
8.7.3.2 Forecast Trend (2024-2032)
8.8 Global Dry Eye Syndrome Market by Region
8.8.1 North America
8.8.1.1 Historical Trend (2018-2023)
8.8.1.2 Forecast Trend (2024-2032)
8.8.2 Europe
8.8.2.1 Historical Trend (2018-2023)
8.8.2.2 Forecast Trend (2024-2032)
8.8.3 Asia Pacific
8.8.3.1 Historical Trend (2018-2023)
8.8.3.2 Forecast Trend (2024-2032)
8.8.4 Latin America
8.8.4.1 Historical Trend (2018-2023)
8.8.4.2 Forecast Trend (2024-2032)
8.8.5 Middle East and Africa
8.8.5.1 Historical Trend (2018-2023)
8.8.5.2 Forecast Trend (2024-2032)
9 North America Dry Eye Syndrome Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
10 Europe Dry Eye Syndrome Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Historical Trend (2018-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 France
10.3.1 Historical Trend (2018-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Historical Trend (2018-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific Dry Eye Syndrome Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2023)
11.1.2 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Historical Trend (2018-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 India
11.3.1 Historical Trend (2018-2023)
11.3.2 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Historical Trend (2018-2023)
11.4.2 Forecast Trend (2024-2032)
11.5 Australia
11.5.1 Historical Trend (2018-2023)
11.5.2 Forecast Trend (2024-2032)
11.6 Others
12 Latin America Dry Eye Syndrome Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2023)
12.1.2 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Historical Trend (2018-2023)
12.2.2 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Historical Trend (2018-2023)
12.3.2 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa Dry Eye Syndrome Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2023)
13.1.2 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2023)
13.2.2 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Historical Trend (2018-2023)
13.3.2 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Historical Trend (2018-2023)
13.4.2 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Company Profiles
16.2.1 Akorn, Incorporated.
16.2.1.1 Company Overview
16.2.1.2 Company Description
16.2.2 AbbVie
16.2.2.1 Company Overview
16.2.2.2 Company Description
16.2.3 Auven Therapeutics
16.2.3.1 Company Overview
16.2.3.2 Company Description
16.2.4 Nicox S.A.
16.2.4.1 Company Overview
16.2.4.2 Company Description
16.2.5 Novartis AG
16.2.5.1 Company Overview
16.2.5.2 Company Description
16.2.6 Others
17 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Dry Eye Syndrome Market: Key Industry Highlights, 2018 and 2032
2. Global Dry Eye Syndrome Historical Market: Breakup by Disease Type (USD Billion), 2018-2023
3. Global Dry Eye Syndrome Market Forecast: Breakup by Disease Type (USD Billion), 2024-2032
4. Global Dry Eye Syndrome Historical Market: Breakup by Drug Type (USD Billion), 2018-2023
5. Global Dry Eye Syndrome Market Forecast: Breakup by Drug Type (USD Billion), 2024-2032
6. Global Dry Eye Syndrome Historical Market: Breakup by Product (USD Billion), 2018-2023
7. Global Dry Eye Syndrome Market Forecast: Breakup by Product (USD Billion), 2024-2032
8. Global Dry Eye Syndrome Historical Market: Breakup by Distribution Channel (USD Billion), 2018-2023
9. Global Dry Eye Syndrome Market Forecast: Breakup by Distribution Channel (USD Billion), 2024-2032
10. Global Dry Eye Syndrome Historical Market: Breakup by Region (USD Billion), 2018-2023
11. Global Dry Eye Syndrome Market Forecast: Breakup by Region (USD Billion), 2024-2032
12. North America Dry Eye Syndrome Historical Market: Breakup by Country (USD Billion), 2018-2023
13. North America Dry Eye Syndrome Market Forecast: Breakup by Country (USD Billion), 2024-2032
14. Europe Dry Eye Syndrome Historical Market: Breakup by Country (USD Billion), 2018-2023
15. Europe Dry Eye Syndrome Market Forecast: Breakup by Country (USD Billion), 2024-2032
16. Asia Pacific Dry Eye Syndrome Historical Market: Breakup by Country (USD Billion), 2018-2023
17. Asia Pacific Dry Eye Syndrome Market Forecast: Breakup by Country (USD Billion), 2024-2032
18. Latin America Dry Eye Syndrome Historical Market: Breakup by Country (USD Billion), 2018-2023
19. Latin America Dry Eye Syndrome Market Forecast: Breakup by Country (USD Billion), 2024-2032
20. Middle East and Africa Dry Eye Syndrome Historical Market: Breakup by Country (USD Billion), 2018-2023
21. Middle East and Africa Dry Eye Syndrome Market Forecast: Breakup by Country (USD Billion), 2024-2032
22. Global Dry Eye Syndrome Market Structure
Key Questions Answered in the Report
The market is projected to grow at a CAGR of 6.8% between 2024 and 2032.
The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach about USD 7.72 billion by 2032.
The major drivers of the market are the rising occurrence of dry eye syndrome, and changing lifestyles.
The key trends guiding the growth of the market include the rising research and development activities in the industry and increasing geriatric population.
The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Evaporative and aqueous dry eye syndromes are the major disease types in the market.
Anti-inflammatory drugs, lubricant eye drops, and autologous serum eye drops are the major drug types in the market.
Liquid drops, gel, liquid wipes, and eye ointment, among others, are the major products in the market.
The major distribution channels in the market are hospital pharmacies, retail pharmacies, and online pharmacies.
The major players in the global dry eye syndrome market are Akorn, Incorporated., AbbVie, Auven Therapeutics, Nicox S.A., and Novartis AG, among others.
In 2023, the global dry eye syndrome market attained a value of nearly USD 4.26 billion.
Analyst Review
The global dry eye syndrome market attained a value of USD 4.26 billion in 2023, driven by the rising geriatric population. Aided by the technological innovations, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 6.8%. The market is projected to reach USD 7.72 billion by 2032.
EMR's meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its disease types, the industry can be segmented into evaporative and aqueous dry eye syndromes. On the basis of drug types, the industry is categorised into anti-inflammatory drugs, lubricant eye drops, and autologous serum eye drops. On the basis of products, the industry is divided into liquid drops, gel, liquid wipes, eye ointment, and others. On the basis of distribution channels, the industry is categorised into hospital pharmacies, retail pharmacies, and online pharmacies. The major regional markets for the product are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Akorn, Incorporated., AbbVie, Auven Therapeutics, Nicox S.A., Novartis AG, and others.
EMR's research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER